2024-11-16 18:40:37
Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Health/ 2023-07-22
Merck Grants Exclusive License to Vertex...

DARMSTADT,Germany,Jan. 24,2019-- Not intended for UK- or US-based media Exclusive license grants Vertex one clinical and one pre-clinical DN...

Inovio Reports 2nd Patient Achieving Full Remission from HPV-Related Head & Neck Cancer after Treatment with Synthetic DNA Vaccine and a PD-1 Checkpoint Inhibitor
Corporate/ 2023-07-23
Inovio Reports 2nd Patient Achieving Ful...

PLYMOUTH MEETING,Pennsylvania,Jan. 24,2019--Inovio Pharmaceuticals,Inc. (NASDAQ: INO) today announced that a second patient with HPV-related...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release